[go: up one dir, main page]

PT1051155E - Solucoes nasais - Google Patents

Solucoes nasais

Info

Publication number
PT1051155E
PT1051155E PT99904823T PT99904823T PT1051155E PT 1051155 E PT1051155 E PT 1051155E PT 99904823 T PT99904823 T PT 99904823T PT 99904823 T PT99904823 T PT 99904823T PT 1051155 E PT1051155 E PT 1051155E
Authority
PT
Portugal
Prior art keywords
nasa
solutions
liquid
nasal
inter alia
Prior art date
Application number
PT99904823T
Other languages
English (en)
Inventor
Matthias Seidel
Christopher Buckley
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of PT1051155E publication Critical patent/PT1051155E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT99904823T 1998-01-30 1999-01-28 Solucoes nasais PT1051155E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98810069 1998-01-30

Publications (1)

Publication Number Publication Date
PT1051155E true PT1051155E (pt) 2002-10-31

Family

ID=8235913

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99904823T PT1051155E (pt) 1998-01-30 1999-01-28 Solucoes nasais

Country Status (12)

Country Link
EP (1) EP1051155B1 (pt)
JP (1) JP4603687B2 (pt)
AT (1) ATE219657T1 (pt)
AU (1) AU741364B2 (pt)
CA (1) CA2311530C (pt)
DE (1) DE69901936T2 (pt)
DK (1) DK1051155T3 (pt)
ES (1) ES2180274T3 (pt)
IL (1) IL136591A (pt)
NZ (1) NZ505919A (pt)
PT (1) PT1051155E (pt)
WO (1) WO1999038492A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
CN1164271C (zh) * 1999-06-22 2004-09-01 贝林格尔·英格海姆国际有限公司 稳定的丁苄唑啉和氧甲唑啉溶液
DE60209511T2 (de) * 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
BG65734B1 (bg) * 2002-02-22 2009-09-30 Био Терапютикс - Еоод Течен мукоадхезивен фармацевтичен състав
WO2004000272A1 (en) * 2002-06-20 2003-12-31 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
US7714011B2 (en) 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20040235807A1 (en) * 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
KR20060038407A (ko) 2003-06-30 2006-05-03 알자 코포레이션 비휘발성 반대이온을 포함하는 코팅된 미세돌출부용 제제
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
JP4956981B2 (ja) * 2005-01-05 2012-06-20 大正製薬株式会社 オキシメタゾリン含有水性組成物
GB2423711B (en) 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US8940796B2 (en) 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
DE102008007198A1 (de) * 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
WO2010042701A2 (en) * 2008-10-10 2010-04-15 Schering Corporation Corticosteroid compositions and methods of treatments thereof
DE102013001151A1 (de) 2013-01-24 2014-07-24 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
DE202013000748U1 (de) 2013-01-24 2013-02-19 Merz Pharma Gmbh & Co. Kgaa Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit
PL2759290T3 (pl) 2013-01-24 2020-03-31 Merz Pharma Gmbh & Co. Kgaa Płynny preparat w aerozolu do stosowania donosowego z wydłużonym miejscowym czasem działania
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
EP2978407B1 (en) * 2013-03-29 2020-05-06 Santa Farma Ilaç Sanayi A.S. Aqueous solution composition containing ipratropium and oxymetazoline
EP3021835B1 (en) 2013-07-17 2017-05-10 Dow Global Technologies LLC Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
KR101756095B1 (ko) 2013-09-25 2017-07-10 다우 글로벌 테크놀로지스 엘엘씨 셀룰로스 에테르를 포함하는, 점막에 적용하기 위한 조성물
UA117544C2 (uk) * 2014-12-24 2018-08-10 Ядран - Галенскі Лабораторій Д.Д. Назальна композиція із вмістом морської води як ексципієнтом, що покращує стабільність
CA3060078A1 (en) * 2017-04-17 2018-10-25 Thrimoorthy Potta Epinephrine spray formulations
CN112512506A (zh) * 2018-06-13 2021-03-16 希克玛药物美国股份有限公司 肾上腺素喷雾制剂
LT3820439T (lt) 2018-09-11 2022-01-10 Lead Biotherapeutics Ltd. Mukoadhezinė dispersinė nanodalelių sistema ir jos gamybos būdas

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62292719A (ja) * 1986-06-12 1987-12-19 Kaken Pharmaceut Co Ltd 外用澄明水溶性製剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
ATE158172T1 (de) * 1992-05-26 1997-10-15 Procter & Gamble Pulverförmige pharmazeutische zusammensetzung
CA2101126A1 (en) * 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
ES2194867T3 (es) * 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.
JPH07109228A (ja) * 1993-10-08 1995-04-25 Earth Chem Corp Ltd リゾチーム配合口腔用組成物
DE69433133T2 (de) * 1993-12-17 2004-04-01 Mochida Pharmaceutical Co. Ltd. Lösliches thrombomodulin enthaltende zubereitung
JP3269770B2 (ja) * 1995-03-02 2002-04-02 参天製薬株式会社 再分散性の優れたイオン性高分子配合水性懸濁点眼剤
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
WO1999016471A1 (fr) * 1997-10-01 1999-04-08 Wakamoto Pharmaceutical Co., Ltd. Compositions d'emulsions de type aqueux

Also Published As

Publication number Publication date
IL136591A (en) 2005-08-31
ES2180274T3 (es) 2003-02-01
EP1051155B1 (en) 2002-06-26
DE69901936D1 (de) 2002-08-01
DE69901936T2 (de) 2002-11-28
DK1051155T3 (da) 2002-09-16
IL136591A0 (en) 2001-06-14
EP1051155A1 (en) 2000-11-15
WO1999038492A1 (en) 1999-08-05
AU2519899A (en) 1999-08-16
AU741364B2 (en) 2001-11-29
CA2311530C (en) 2008-06-10
JP4603687B2 (ja) 2010-12-22
ATE219657T1 (de) 2002-07-15
JP2002501884A (ja) 2002-01-22
CA2311530A1 (en) 1999-08-05
NZ505919A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
PT1051155E (pt) Solucoes nasais
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
SE0001899D0 (sv) New compounds
DE69523951D1 (de) Stabilisierung der prostaglandinzusammensetzungen
SE9200951D0 (sv) Pharmaceutical composition containing a defined lipid system
DE60108236D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
BR0109943A (pt) Composições farmacêuticas
AU3227700A (en) Skin sanitizing compositions
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
ATE241348T1 (de) Nimesulide-haltige topische arzneimittel
DE69911388D1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
CA2305933A1 (fr) Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
WO2003065980A3 (en) Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
DK1092431T3 (da) Lasofoxifenpræparater
BR9712993A (pt) Composições orais contendo gluconato estanoso.
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
MD1473G2 (ro) Remediu antiherpetic
DE60003074D1 (de) Fusidinsäure-derivate
ATE298564T1 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel
MXPA03010821A (es) Composiciones de aroma y fragancias.
BR0213463A (pt) Composições farmacêuticas contendo macrólidos
TR200001466T2 (tr) Burun solüsyonları